Source: Annual Congress 2006 - From genes to outcome: a long distance
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. M. Popa, I. Popa, L. Pop, Z. Popa, S. Turcu (Timisoara, Romania). How much genotype influences cystic fibrosis associated liver disease?. Eur Respir J 2006; 28: Suppl. 50, 4119

Member's Comments

No comment yet.

Related content which might interest you: Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Genotype and progressive lung damage in adult cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 502s Year: 2003 Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series Source: Eur Respir J 2006; 28: Suppl. 50, 263s Year: 2006 Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 A model for active and healthy ageing with a rare genetic disease: cystic fibrosis Source: Eur Respir J 2016; 47: 714-719 Year: 2016 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Prevalence of acute liver dysfunction and chronic liver disease in an Irish adult cystic fibrosis population Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis Source: Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018 Year: 2019 Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 Update on pancreatic and liver disease in cystic fibrosis Source: Virtual Congress 2020 – Updates in cystic fibrosis Year: 2020 Elucidating progression of early cystic fibrosis lung disease Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017 Year: 2017 Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002 Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019 Year: 2020 Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017 Year: 2018 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018 Year: 2018 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014